JP7841530B2 - 生体粒子分析方法及び生体粒子分析用試薬キット - Google Patents

生体粒子分析方法及び生体粒子分析用試薬キット

Info

Publication number
JP7841530B2
JP7841530B2 JP2023505221A JP2023505221A JP7841530B2 JP 7841530 B2 JP7841530 B2 JP 7841530B2 JP 2023505221 A JP2023505221 A JP 2023505221A JP 2023505221 A JP2023505221 A JP 2023505221A JP 7841530 B2 JP7841530 B2 JP 7841530B2
Authority
JP
Japan
Prior art keywords
substance
particle
biological
biological particles
capture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023505221A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022190733A1 (https=
Inventor
真寛 松本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sony Corp
Sony Group Corp
Original Assignee
Sony Corp
Sony Group Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sony Corp, Sony Group Corp filed Critical Sony Corp
Publication of JPWO2022190733A1 publication Critical patent/JPWO2022190733A1/ja
Application granted granted Critical
Publication of JP7841530B2 publication Critical patent/JP7841530B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C12M1/34—Measuring or testing with condition measuring or sensing means, e.g. colony counters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Sustainable Development (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2023505221A 2021-03-10 2022-02-04 生体粒子分析方法及び生体粒子分析用試薬キット Active JP7841530B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021038639 2021-03-10
JP2021038639 2021-03-10
PCT/JP2022/004477 WO2022190733A1 (ja) 2021-03-10 2022-02-04 生体粒子分析方法及び生体粒子分析用試薬キット

Publications (2)

Publication Number Publication Date
JPWO2022190733A1 JPWO2022190733A1 (https=) 2022-09-15
JP7841530B2 true JP7841530B2 (ja) 2026-04-07

Family

ID=83227842

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023505221A Active JP7841530B2 (ja) 2021-03-10 2022-02-04 生体粒子分析方法及び生体粒子分析用試薬キット

Country Status (4)

Country Link
US (1) US20240310375A1 (https=)
JP (1) JP7841530B2 (https=)
CN (1) CN117015710A (https=)
WO (1) WO2022190733A1 (https=)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004520037A (ja) 2001-01-16 2004-07-08 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 分泌タンパク質を発現する細胞の単離
JP2005526950A (ja) 2001-07-27 2005-09-08 ロンザ・グループ・アーゲー 抗体発現細胞を選択する方法
JP2010522561A (ja) 2007-03-26 2010-07-08 コドン デバイシズ インコーポレイテッド 関心対象のタンパク質の細胞表面ディスプレイ、スクリーニング、および産生
JP2011527576A (ja) 2008-07-09 2011-11-04 メルク・シャープ・エンド・ドーム・コーポレイション 真核生物における全長抗体の表面提示
JP2012523569A (ja) 2009-04-08 2012-10-04 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Ｄｎａ−細胞コンジュゲート
JP2018535652A (ja) 2015-09-24 2018-12-06 アブビトロ， エルエルシー 親和性−オリゴヌクレオチドコンジュゲートおよびその使用
WO2020129462A1 (ja) 2018-12-21 2020-06-25 ソニー株式会社 粒子確認方法、粒子捕捉用チップ、及び粒子分析システム
WO2021161893A1 (ja) 2020-02-14 2021-08-19 ソニーグループ株式会社 分析方法、分析システム、及び分析用表面

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004520037A (ja) 2001-01-16 2004-07-08 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 分泌タンパク質を発現する細胞の単離
JP2005526950A (ja) 2001-07-27 2005-09-08 ロンザ・グループ・アーゲー 抗体発現細胞を選択する方法
JP2010522561A (ja) 2007-03-26 2010-07-08 コドン デバイシズ インコーポレイテッド 関心対象のタンパク質の細胞表面ディスプレイ、スクリーニング、および産生
JP2011527576A (ja) 2008-07-09 2011-11-04 メルク・シャープ・エンド・ドーム・コーポレイション 真核生物における全長抗体の表面提示
JP2012523569A (ja) 2009-04-08 2012-10-04 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Ｄｎａ−細胞コンジュゲート
JP2018535652A (ja) 2015-09-24 2018-12-06 アブビトロ， エルエルシー 親和性−オリゴヌクレオチドコンジュゲートおよびその使用
WO2020129462A1 (ja) 2018-12-21 2020-06-25 ソニー株式会社 粒子確認方法、粒子捕捉用チップ、及び粒子分析システム
WO2021161893A1 (ja) 2020-02-14 2021-08-19 ソニーグループ株式会社 分析方法、分析システム、及び分析用表面

Also Published As

Publication number Publication date
WO2022190733A1 (ja) 2022-09-15
US20240310375A1 (en) 2024-09-19
CN117015710A (zh) 2023-11-07
JPWO2022190733A1 (https=) 2022-09-15

Similar Documents

Publication Publication Date Title
CN112105912B (zh) 用于单生物纳米颗粒分析的方法和设备
TWI758265B (zh) 原位產生之微流體分析結構，相關套組，及其使用方法
EP3248018B1 (en) Devices and systems for molecular barcoding of nucleic acid targets in single cells
CN115468894A (zh) 用于研究生物细胞的方法和系统
JP7816150B2 (ja) 生体粒子分析方法及び生体粒子分析システム
JP7388131B2 (ja) 微小粒子回収方法、微小粒子分取用マイクロチップ、微小粒子回収装置、エマルションの製造方法、及びエマルション
JP7694382B2 (ja) 標的分子の検出方法
JP7740398B2 (ja) 粒子確認方法、粒子捕捉用チップ、及び粒子分析システム
US20240159736A1 (en) Method of selecting cells
JP7841530B2 (ja) 生体粒子分析方法及び生体粒子分析用試薬キット
WO2023080102A1 (ja) 血液中の脳神経細胞由来のエクソソームに結合したアミロイドβの検出方法、血液中の脳神経細胞由来のエクソソームに結合したアミロイドβの検出用キット、及び脳内のアミロイドβの蓄積レベルを評価する方法
JP4840398B2 (ja) 抗原の分離装置並びにこれを利用した抗原の計測方法及び装置
US11060964B2 (en) Cell detection method
US20250271415A1 (en) Bioparticle analysis system, information processing device, and bioparticle analysis method
Duroux et al. Novel photonic technique creates micrometer resolution protein arrays and provides a new approach to coupling of genes, peptide hormones and drugs to nanoparticle carriers
WO2024085141A1 (ja) 流体デバイス及び標的分子の検出方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251226

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260224

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260309

R150 Certificate of patent or registration of utility model

Ref document number: 7841530

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150